{"disease":{"id":"vulvar-diseases","name":"vulvar diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06495554","title":"Danish Vulva Cancer Recurrence Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":1295,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT05890092","title":"Vulvar Disease in Nigeria Observational Study","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"KDRS ltd","has_results":false},{"nct_id":"NCT02858310","title":"E7 TCR T Cells for Human Papillomavirus-Associated Cancers","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":224,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06070454","title":"Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions","phase":"NA","overall_status":"RECRUITING","enrollment_count":91,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT03792516","title":"Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT03444727","title":"Treatment Prior to Injection and Biopsy of the Vulva","phase":"NA","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"University of Missouri-Columbia","has_results":false},{"nct_id":"NCT05478746","title":"Effects of Flourish HEC on Localized Provoked Vulvodynia","phase":"NA","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Vaginal Biome Science","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}